Synapse - Radiology, Department of

Search Within

Radiology, Department of

Results (97)

Pralatrexate (PDX) produces a high and durable complete response rate in patients with chemotherapy resistant T-cell lymphomas

Meeting Abstract

O'Connor, O. A.; Hamlin, P.; Moskowitz, C.; Portlock, C.; Sarasohn, D.; Dumitrescu, O.; Neylon, E.; Patterson, M.; Zelenetz, A.; Saunders, M.; more...
Annals of Oncology (2008)

Fulltext@MSK | Save

NCCN Task Force report: Positron emission tomography (PET)/computed tomography (CT) scanning in cancer

Journal Article

Podoloff, D. A.; Advani, R. H.; Allred, C.; Benson, A. B. 3rd; Brown, E.; Burstein, H. J.; Carlson, R. W.; Coleman, R. E.; Czuczman, M. S.; Delbeke, D.; more...
Journal of the National Comprehensive Cancer Network (2007)

Fulltext@MSK | Save

Automated matching and segmentation of lymphoma on serial CT examinations

Journal Article

Yan, J.; Zhao, B.; Curran, S.; Zelenetz, A.; Schwartz, L. H.
Medical Physics (2007)

Fulltext@MSK | Save

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma

Journal Article

O'Connor, O. A.; Hamlin, P. A.; Portlock, C.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Macgregor-Cortelli, B.; Neylon, E.; Sarasohn, D.; Dumetrescu, O.; more...
British Journal of Haematology (2007)

Fulltext@MSK | Save

FDG-PET Lymphoma Demonstration Project Invitational Workshop

Journal Article

Kelloff, G. J.; Sullivan, D. M.; Wilson, W.; Cheson, B.; Juweid, M.; Mills, G. Q.; Zelenetz, A. D.; Horning, S. J.; Weber, W.; Sargent, D. J.; more...
Academic Radiology (2007)

Fulltext@MSK | Save

Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma

Journal Article

Iwamoto, F. M.; Schwartz, J.; Pandit-Taskar, N.; Peak, S.; Divgi, C. R.; Zelenetz, A. D.; Humm, J.; Abrey, L. E.
Cancer (2007)

Fulltext@MSK | Save

Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP for mantle cell lymphoma demonstrates RIT can induce molecular remissions

Meeting Abstract

Zelenetz, A. D.; Noy, A.; Pandit-Taskar, N.; Scordo, M.; Rijo, I.; Zhou, Y.; O'Donoghue, J. A.; Divgi, C.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience

Meeting Abstract

O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; more...
Blood (2006)

Fulltext@MSK | Save

Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL

Meeting Abstract

Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
Blood (2006)

Fulltext@MSK | Save

Marker-controlled watershed for lymphoma segmentation in sequential CT images

Journal Article

Yan, J.; Zhao, B.; Wang, L.; Zelenetz, A.; Schwartz, L. H.
Medical Physics (2006)

Fulltext@MSK | Save